Clariscan 0.5 Solution for Injection
Marketer
GE Healthcare Inc
Salt Composition
Gadobenate dimeglumine (0.5mg)
Overview Clariscan 0.5 Solution for Injection
Gadolinium-based Clariscan 0.5 injection serves as an MRI contrast medium, improving the visualization of internal anatomy prior to magnetic resonance imaging. This enhanced imaging aids in diagnosis and subsequent treatment planning. Administration is strictly by injection from a qualified medical professional, such as a radiologist. Potential adverse effects may include nausea, emesis, cephalalgia, local injection site reactions, and pyrexia. Report any persistent or troublesome side effects to your physician immediately.
Uses of Clariscan 0.5 Solution for Injection
Imaging contrast medium
Major Benefits of Clariscan 0.5 Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
Common Side effects of Clariscan 0.5 Solution for Injection:
- Nausea
- Vomiting
- Headache
- Injection site reaction
- Fever
How to use Clariscan 0.5 Solution for Injection:
Your healthcare provider will instruct you on the proper administration of this medication.
How Clariscan 0.5 Solution for Injection works:
Clariscan 0.5 Injectable Solution, a paramagnetic contrast agent, exhibits magnetization upon exposure to a magnetic field. This substantial induced magnetization creates a strong localized field, accelerating the relaxation of nearby water protons. This effect boosts the signal intensity (brightness) of the corresponding tissue in magnetic resonance imaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Clariscan 0.5 Injection Solution is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Clariscan 0.5 Injection Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCAUTION
Administering Clariscan 0.5 Injection Solution to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
Clariscan 0.5 Injection Solution's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Clariscan 0.5 injectable solution poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverSAFE IF PRESCRIBED
The injectable formulation Clariscan 0.5 appears to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates that altering the Clariscan 0.5 injection dosage for these patients may be unnecessary. However, physician consultation is recommended.
What if you forget to take Clariscan 0.5 Solution for Injection :
Omit a dose of Clariscan 0.5 injectable solution? Seek your physician's advice.
Facts to Know About Clariscan 0.5 Solution for Injection
| Label | Value |
|---|---|
| Chemical Type | Hexosamine sugars |
| Developing Habits | No. |
| Treatment Category | ALTERNATIVES |
3,018 People bought this recently